Company Name
MacuLogix
Description
MacuLogix® is an innovator in the early detection and tracking of age-related macular degeneration (AMD). The company’s AdaptDx® dark adaptometer is the first practical device for detecting AMD at least three years earlier than other technology. Once AMD is detected, the AdaptDx, in conjunction with more frequent exams and the use of imaging technology, is used to baseline and track the progression of this chronic disease in order to preserve vision with proactive intervention. MacuLogix's mission is to empower primary eye care professionals with the technology and tools needed to take better care of their patients. Each AdaptDx® purchased is supported by our AMD Excellence Program, which is designed to help you achieve your patient care and practice revenue goals. Our team of experienced practice management and optimization consultants will partner with you each step of the way.
Website